Brazil researchers report disappointing 50.4% efficacy for CoronaVac January 12, 2021 at 08:13AM

A coronavirus vaccine developed by China's Sinovac showed "general efficacy" of 50.4% in a late-stage trial in Brazil, researchers said on Tuesday, barely enough for regulatory approval and far short of earlier indications.